 

r
FINAL DIAGNOSIS:

SEGMENTAL MASTECTOMY -
PART 1 %lilm QUWA, I. I CM, NOTTINGHAM SCORE 6/9 (TUBULES 3, NUCLEAR GRADE 2
M T0515 I
DllJCTAL C)ARCINOMA IN SITU, SOLID TYPE, NUCLEAR GRADE 2. REPRESENTING 5% OF THE TUMOR
VOLUME.
ANGIOLYMPHATIC INVASION IDENTIFIED.
INVASIVE TUMOR IS 0.5 CM FROM SUPERIOR MARGIN.
MARGINS FREE OF TUMOR.
CHANGES CONSISTENT WITH BIOPSY SITE.
FIBROCYSTIC CHANGES.

955.50 9‘

PART 2: RIGHT AXILLA, SENTINEL NODE #I, BIOPSY -
TWO LYMPH NODES (0/2), NEGATIVE FOR TUMOR.

 

*-

CASE SYNOPSIS: low 4 ’3
SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST CW, 1-»wa W: W‘ VOW/3
LATERALITY: Right _ g , c 5/0,
PROCEDURE: Segmental J'ﬁ' 4’ “‘4" N” 7 37‘3“ ’4‘“
LOCATION: Upper outer quadrant
SIZE OF TUMOR: Maximum dimension invasive component. 1 1 cm
MULTICENTRICITYIMULTIFOCALITY OF INVASIVE FOCI:

No
TUMOR TYPE (Invasive component):

Ductal adenocarcinoma. NOS
NOTTINGHAM SCORE: Nuclear grade: 2

Tubule formation: 3

Mitotic activity score: 1

Total Nottingham score: 6

Nottingham grade (1. 2. 3): 2

ANGIOLYMPHATIC INVASION: Yes
DERMAL LYMPHATIC INVASION: Not applicable
CALCIFICATION: No
TUMOR TYPE, IN SITU: Solid
0 DCIS admixed with Invasive carcinoma

Percent of tumor occupied by' In situ component: 5 %
SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT.

No

Distance of Invasive tumor to closest margin. 5.0 mm
SURG MARGINS INVOLVED BY IN SITU COMPONENT.

No
PAGET'S DISEASE OF NIPPLE: No uum: 4:261“; czgz-FIEEIIil-‘aizg- -uu7ssacaance9d
LYMPH NODES POSITIVE: 0
LYMPH nooes sxmmen: 2 III llllllllllllllllllllllllll|l|||lllIllllllllllllIlllllllllllll|||eel
MET”°°‘S’ °F ”MP” "°°E EXAM'mg'Q'ti llllll Illllllllllllllllllllllllllllllllllllllllllllll llllll
SENTINEL "one METASTASIS: No s 3'” Ill llllllllllllllllllllllllllll lllll |||llllllllllllllllllllll I"

ONLY KERATIN POSITIVE CELLS ARE PRESENT:
No
LYMPH NODE METASTASIS(- -ES) WITH EXTRACAPSULAR EXTENSION.
METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NODE (IF APPLICABLE):

No
SKIN INVOLVED (ULCERATION): No
T STAGE, PATHOLOGIC: pT1c
N STAGE, PATHOLOGIC: pNO
M STAGE, PATHOLOGIC: pMO
ESTROGEN RECEPTORS: positive crite-Ia

    

PROGESTERONE RECEPTORS: positive 5 $553,313. .
HERZINEU: zero or 1+ MW

